Pharmaceuticals and Medical Equipment in Japan

October 2019 | 23 pages | ID: PDD26B27C4DEN
Euromonitor International Ltd

Abstracts

In an effort to constrain the steady rise in healthcare expenses due to the increasing burden on state finances, Japan’s government decided to reduce drug prices covered by public health insurance by nearly 1.5% in April 2018. The measure, which also narrowed down the type of drugs eligible for the country’s price maintenance premium by an estimated 35%, aimed at reflecting real market prices of pharmaceuticals as well. Exemptions included only first-in-class therapies and the two next-in-class...

Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals and Medical Equipment market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Product coverage: Medical and Surgical Equipment, Pharmaceuticals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Pharmaceuticals and Medical Equipment market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Prospects
New Drug Pricing Policy Likely To Deter Medium-term Growth Potential and Reduce Market Competition
Japan's Medical Devices Sector To Suffer From Reduced Public Funding for Healthcare Infrastructure Development
Exports To Continue Driving the Industry Stronger Than Market Demand
Competitive Landscape
M&a in Japan To Keep Experiencing Rapid Growth
Industry Overview
  Chart 1 Turnover 2003-2023, LCU million
  Chart 2 Value Added 2013-2018, LCU million
  Chart 3 Profit and Profit Margin 2013-2018
  Chart 4 Turnover and Growth by Category 2018, LCU million
  Chart 5 Pharmaceuticals Turnover 2003-2023, LCU million
  Chart 6 Medical And Surgical Equipment Turnover 2003-2023, LCU million
  Chart 7 Absolute Growth by Category, LCU million
Cost Structure
  Chart 8 Cost Structure 2018, LCU million
  Chart 9 B2B Costs and Growth 2018, LCU million
Trade
  Chart 10 Imports, Exports and Trade Balance 2013-2018, LCU million
  Chart 11 Exports 2013-2018, LCU million
  Chart 12 Exports Share by Category 2013-2018, % of Total Exports
  Chart 13 Exports by Country 2013-2018, LCU million
  Chart 14 Exports Share by Country 2013-2018, % of Total Exports
  Chart 15 Imports 2013-2018, LCU million
  Chart 16 Imports Share by Category 2013-2018, % of Total Imports
  Chart 17 Imports by Country 2013-2018, LCU million
  Chart 18 Imports Share by Country 2013-2018, % of Total Imports
Market Structure
  Chart 19 Market Structure by Category 2013-2018, LCU million
  Chart 20 Market Share by Category 2013-2018, % of Total Market
  Chart 21 Market Structure 2013-2018, LCU million
Buyers
  Chart 22 Market Structure by Buyer 2018, LCU million
  Chart 23 B2B Buyers and Growth 2018, LCU million
Firmographics
  Chart 24 Employment Statistics and Productivity 2013-2018
  Chart 25 Number of Companies by Company's Size 2013-2018
  Chart 26 Firmographics Distribution by Company Size 2013-2018, % of Total Companies
  Chart 27 Firmographics Distribution by Turnover 2013-2018, % of total Turnover
  Chart 28 Industry Concentration 2013-2018, % Share of Turnover
  Chart 29 Top Companies' Shares 2018, % of Turnover
  Chart 30 Top 5 Companies' Share Dynamics 2013-2018, % of Turnover
  Chart 31 Turnover Performance by Company 2013-2018
Digital Business
  Chart 32 Share of E-Commerce Activities 2018-2023, %
  Chart 33 Number of Companies Receiving Orders Online 2013-2018
  Chart 34 Number of Companies Placing Orders Online 2013-2018
  Chart 35 Revenue from E-Commerce, 2013-2018, LCU million
Industry Context
  Chart 36 Attractiveness Index in Selected Industries 2018
  Chart 37 Industry vs GDP Performance 2003-2023, % y-o-y Growth
  Chart 38 Pharmaceuticals and medical equipment vs Other Industries 2003-2023, LCU million
  Chart 39 Industry Turnover by Region 2018, USD million
  Chart 40 Pharmaceuticals and Medical Equipment in Asia Pacific 2003-2023, USD million